Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

FDA Drug Recalls

1,563 recalls, newest first

Class II · Moderate risk

HCG liquid

Lack of sterility assurance.

Terminated Sterility / contamination Hiers Enterprises, LLC dba Northwest Compounding Pharmacy D-0395-2019
Class II · Moderate risk

Cefdinir for Oral Suspension USP

CGMP Deviations: Product complaints received indicating reconstituted suspension was observed to be thick.

Terminated cGMP deviation Lupin Pharmaceuticals Inc. NDC 68180-723-20 D-0376-2019
Class II · Moderate risk

Cefdinir for Oral Suspension USP

CGMP Deviations: Product complaints received indicating reconstituted suspension was observed to be thick.

Terminated cGMP deviation Lupin Pharmaceuticals Inc. NDC 68180-722-20 D-0375-2019
Class II · Moderate risk

Dianeal Low Calcium

Lack of Assurance of Sterility: Confirmed customer complaints for leaks on the tubing.

Terminated Sterility / contamination Baxter Healthcare Corporation NDC 0941-0424-52 D-0351-2019

Recalls by year